Europe — EMA

Otrivin Säilytysaineeton (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin Säilytysaineeton, is a topical nasal decongestant presented as a solution for intranasal use.

Xylometazoline Hydrochloride

Request sourcing

Pack/s

What is Xylometazoline Hydrochloride?

Xylometazoline hydrochloride, the active ingredient in Otrivin Säilytysaineeton, is a topical nasal decongestant presented as a solution for intranasal use. It relieves nasal congestion associated with colds, sinusitis, and allergic rhinitis in adults and children. GNH USA supplies Otrivin Säilytysaineeton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin Säilytysaineeton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Xylometazoline Hydrochloride used for?

Otrivin Säilytysaineeton contains Xylometazoline, a selective α‑adrenergic agonist that reduces nasal mucosal swelling. It is indicated for: - Common cold: temporary relief of nasal congestion. - Acute sinusitis: reduction of nasal blockage. - Allergic rhinitis: easing nasal stuffiness. - Nasal surgery recovery: supporting airway patency.

What are the side effects of Xylometazoline Hydrochloride?

Xylometby

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →